Masimo Corporation Expands Beyond Pulse Oximetry – A Commercial Powerhouse Strategy Focused On New Monitoring Markets!

Masimo Corporation, a global medical technology company, reported strong results in its third quarter of 2025. The company experienced an 8% increase in revenue, driven by sustained demand for its innovative healthcare technologies. The company also delivered a 450 basis point expansion in operating margins and a 38% year-over-year increase in adjusted earnings per share, signaling robust operational efficiency and revenue growth. A key milestone for the quarter was the completion of Sound United’s sale to Harman, reflecting Masimo’s focus on its core healthcare business. The company’s strategic expansion with Philips was another highlight, marking a continued enhancement of Masimo’s market share. Currently, Masimo’s share within Philips’ installed base is significantly lower than its overall market share, presenting an opportunity for future growth. The company is investing in three major growth areas: commercial excellence, intelligent monitoring using AI, and wearable technology.